Saito Biotech Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Legal Opinion on the 2025 Annual Shareholders Meeting of Shandong Saito Biotechnology Co., Ltd.

Remuneration Management System for Directors and Senior Management (May 2026)

Announcement on the Addition of Temporary Proposals for the 2025 Annual Shareholders' Meeting and Supplementary Notice

Resolution Announcement of the 15th Meeting of the 4th Board of Directors

Announcement on participating in the 2026 Shandong-listed companies investor online collective reception day

Progress announcement on the repurchase of company shares

Announcement on Requesting Shareholders' Meeting Authorization for the Board of Directors to Issue Stocks to Specific Objects via Simplified Procedures

Guojin Securities Co., Ltd. Summary Report on the Continuous Supervision of Shandong Saito Biotechnology Co., Ltd.

Announcement on the Reappointment of the Company's Audit Institution for the Year 2026

Guojin Securities Co., Ltd. Continuous Supervision Tracking Report on Shandong Saito Biotechnology Co., Ltd. for the Year 2025

Independent Director's 2025 Annual Work Report (Kang Li)

Independent Director's 2025 Annual Work Report (Zhang Qiming)

Independent Director's 2025 Annual Work Report (Tu Pengfei)

Announcement on the 2025 Annual Performance Online Presentation Meeting

Guojin Securities Co., Ltd. Verification Opinion on the 2025 Annual Internal Control Evaluation Report of Shandong Saito Biotechnology Co., Ltd.

2025 Annual Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Announcement on the Provision for Asset Impairment

Guojin Securities Co., Ltd. Verification Opinion on the Temporary Use of Idle Raised Funds by Shandong Saito Biotechnology Co., Ltd. and Its Wholly-Owned Subsidiary to Supplement Working Capital

Announcement on the Temporary Use of Idle Raised Funds by the Company and Its Wholly-Owned Subsidiary to Supplement Working Capital

Announcement on the Company's and Subsidiaries' Application for Comprehensive Credit Limits and Provision of Guarantees to Banks

Notice of the 2025 Annual Shareholders' Meeting

2025 Annual Work Report of the Board of Directors

Announcement of Resolutions from the 14th Meeting of the 4th Board of Directors

Announcement on the Profit Distribution Plan for the Year 2025

Quarterly Report for Q1 2026

Special Report on the Annual Storage, Management, and Use of Raised Funds for the Year 2025

Verification Report on the Annual Storage, Management, and Use of Raised Funds for the Year 2025

Guojin Securities Co., Ltd. Verification Opinion on the Use and Storage of Raised Funds by Shandong Saito Biotechnology Co., Ltd. for the Year 2025

Special Verification Opinion on the Deduction of Operating Income for the Year 2025

Evaluation Report on the Accounting Firm's Performance for the Year 2025

Report of the Audit Committee on the Accounting Firm's Performance of Supervisory Responsibilities for the Year 2025

Special Audit Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Special Report on the Board's Self-Examination of the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the Progress of Share Repurchase

Announcement on Returning Idle Raised Funds to Supplement Working Capital

Announcement on the progress of repurchasing the company's shares

Announcement on Subsidiaries Receiving European CEP Certificates for Active Pharmaceutical Ingredients

Announcement on Subsidiary Receiving Approval Notice for Chemical API Marketing Application

Announcement on Subsidiary Receiving Approval Notice for Listing Application of Chemical Raw Materials

Announcement on Shareholding of Top Ten Shareholders and Top Ten Unrestricted Shareholders Before Share Repurchase

Share Repurchase Report

Resolutions Announcement of the 13th Meeting of the Fourth Board of Directors

Announcement on the Company's Share Repurchase Plan